China National Medicines Corporation Ltd. (SHA:600511)
28.87
0.00 (0.00%)
Nov 17, 2026, 3:00 PM CST
SHA:600511 Revenue
China National Medicines Corporation had revenue of 13.88B CNY in the quarter ending September 30, 2026, with 0.95% growth. This brings the company's total for the last twelve months to 53.69B, up 3.36% year-over-year. In the year 2025, China National Medicines Corporation had annual revenue of 52.47B with 3.70% growth. That makes China National Medicines Corporation the 1,776th largest company in the world by revenue and 190th in China.
Revenue (ttm)
53.69B
Revenue Growth
+3.36%
P/S Ratio
0.40
Revenue / Employee
17.76M
Employees
3,024
Market Cap
21.78B
Revenue by Segment
- Commercial Segment 51.69B 97.9%
- Others 1.13B 2.1%
Fiscal year ended Dec 31, 2025 See the full SHA:600511 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.47B | 1.87B | 3.70% |
| Dec 31, 2024 | 50.60B | 901.40M | 1.81% |
| Dec 31, 2023 | 49.70B | 4.20B | 9.23% |
| Dec 31, 2022 | 45.50B | -970.02M | -2.09% |
| Dec 31, 2021 | 46.47B | 6.09B | 15.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 291.47B |
| Jointown Pharmaceutical Group | 171.51B |
| C.Q. Pharmaceutical Holding | 80.51B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 78.13B |
| China National Accord Medicines Corporation | 73.36B |
| China Meheco Group | 34.46B |
| Guangxi LiuYao Group | 21.31B |
| Shanghai C&D INNOSTIC Medical Technology Group | 19.44B |
China National Medicines Corporation News
- 4 weeks ago - China National Medicines Corporation Quarterly report: Q3 2026 - Filings
- 2 months ago - China National Medicines Corporation Quarterly report: Q2 2026 - Filings
- 6 months ago - China National Medicines Corporation Quarterly report: Q1 2026 - Filings
- 8 months ago - China National Medicines Corporation Annual report: Q4 2025 - Filings